Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease.
LINC 2, LINC 3, and LINC 4 were clinical trials that showed that osilodrostat rapidly reduced 24-hour mean urinary free cortisol levels, produced sustained improvements in clinical signs and quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results